Skip links

Author: oncologs.com

nrg-oncology-trial-confirms-radiotherapy-as-the-preferred-standard-of-care-post-radical-hysterectomy-for-early-stage-intermediate-risk-cervical-cancer

NRG Oncology Trial Confirms Radiotherapy as the Preferred Standard of Care Post-Radical Hysterectomy for Early-Stage Intermediate-Risk Cervical Cancer

Results from the recent NRG Oncology GOG-0263 phase III clinical trial have brought significant insights into the treatment protocols for early-stage, intermediate-risk cervical carcinoma. This study examined the effects of incorporating cisplatin-based chemotherapy into a regimen of adjuvant radiotherapy following radical hysterectomy and lymphadenectomy. Remarkably,
researchers-unlock-method-to-reactivate-cancer’s-molecular-‘kill-switch’

Researchers Unlock Method to Reactivate Cancer’s Molecular ‘Kill Switch’

In a groundbreaking study published in Nature Communications, researchers from The Jackson Laboratory and UConn Health have revealed the intricate mechanisms by which cancer cells exploit the natural RNA splicing processes that govern gene expression. This research highlights the role of so-called “poison exons,” which
impact-of-postnatal-depression-on-the-oxytocin-system-in-breastfeeding-mothers

Impact of Postnatal Depression on the Oxytocin System in Breastfeeding Mothers

The oxytocin system plays a crucial role in the physiological and emotional landscape of motherhood, particularly during breastfeeding. A recent study conducted by researchers from University College London (UCL) lends insight into how this intricate hormonal pathway may be influenced by postnatal depression (PND). This
groundbreaking-therapeutic-advancements-for-pediatric-brain-tumors

Groundbreaking Therapeutic Advancements for Pediatric Brain Tumors

Brain tumors represent the leading cause of cancer-related mortality among children, with pediatric high-grade gliomas (pHGG) standing out as a particularly lethal subgroup. These aggressive tumors are notoriously resistant to current treatment options, resulting in a median survival time of under 18 months following diagnosis.
pitt-research-unveils-new-insights-into-the-origins-of-ovarian-cancer

Pitt Research Unveils New Insights into the Origins of Ovarian Cancer

Researchers from the University of Pittsburgh have unveiled a groundbreaking discovery that may radically change our understanding of ovarian cancer’s genesis. This pivotal study focuses on a specific subset of mesenchymal stem cells (MSCs) which are observed to play a significant role in the development
fda-approved-drug-reimagined-for-potential-high-grade-glioma-treatment

FDA-Approved Drug Reimagined for Potential High-Grade Glioma Treatment

High-grade glioma represents a particularly aggressive form of brain cancer, affecting both pediatric and adult populations. This type of tumor is notoriously difficult to treat due to specific challenges associated with its location within the brain, the high likelihood of recurrence after initial therapies, and
Explore
Drag